I think AMGN reported sales of $1.2-1.3B for EPO in 2017 on total sales of ~23B. So, a gradual 5% total sales bleed starting next year maybe. Probably will be lost in the noise.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.